These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 25432085)

  • 1. Long-term treadmill exercise attenuates tau pathology in P301S tau transgenic mice.
    Ohia-Nwoko O; Montazari S; Lau YS; Eriksen JL
    Mol Neurodegener; 2014 Nov; 9():54. PubMed ID: 25432085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short-term treadmill exercise increased tau insolubility and neuroinflammation in tauopathy model mice.
    Elahi M; Motoi Y; Matsumoto SE; Hasan Z; Ishiguro K; Hattori N
    Neurosci Lett; 2016 Jan; 610():207-12. PubMed ID: 26592481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assembly of transgenic human P301S Tau is necessary for neurodegeneration in murine spinal cord.
    Macdonald JA; Bronner IF; Drynan L; Fan J; Curry A; Fraser G; Lavenir I; Goedert M
    Acta Neuropathol Commun; 2019 Mar; 7(1):44. PubMed ID: 30885267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stimulation of autophagy reduces neurodegeneration in a mouse model of human tauopathy.
    Schaeffer V; Lavenir I; Ozcelik S; Tolnay M; Winkler DT; Goedert M
    Brain; 2012 Jul; 135(Pt 7):2169-77. PubMed ID: 22689910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temsirolimus attenuates tauopathy in vitro and in vivo by targeting tau hyperphosphorylation and autophagic clearance.
    Jiang T; Yu JT; Zhu XC; Zhang QQ; Cao L; Wang HF; Tan MS; Gao Q; Qin H; Zhang YD; Tan L
    Neuropharmacology; 2014 Oct; 85():121-30. PubMed ID: 24880087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapamycin attenuates the progression of tau pathology in P301S tau transgenic mice.
    Ozcelik S; Fraser G; Castets P; Schaeffer V; Skachokova Z; Breu K; Clavaguera F; Sinnreich M; Kappos L; Goedert M; Tolnay M; Winkler DT
    PLoS One; 2013; 8(5):e62459. PubMed ID: 23667480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics.
    Rosenmann H; Grigoriadis N; Eldar-Levy H; Avital A; Rozenstein L; Touloumi O; Behar L; Ben-Hur T; Avraham Y; Berry E; Segal M; Ginzburg I; Abramsky O
    Exp Neurol; 2008 Jul; 212(1):71-84. PubMed ID: 18490011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lithium treatment arrests the development of neurofibrillary tangles in mutant tau transgenic mice with advanced neurofibrillary pathology.
    Leroy K; Ando K; Héraud C; Yilmaz Z; Authelet M; Boeynaems JM; Buée L; De Decker R; Brion JP
    J Alzheimers Dis; 2010; 19(2):705-19. PubMed ID: 20110614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increase in tau tyrosine phosphorylation correlates with the formation of tau aggregates.
    Vega IE; Cui L; Propst JA; Hutton ML; Lee G; Yen SH
    Brain Res Mol Brain Res; 2005 Aug; 138(2):135-44. PubMed ID: 15913839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphorylated p38MAPK specific antibodies cross-react with sarkosyl-insoluble hyperphosphorylated tau proteins.
    Sahara N; Vega IE; Ishizawa T; Lewis J; McGowan E; Hutton M; Dickson D; Yen SH
    J Neurochem; 2004 Aug; 90(4):829-38. PubMed ID: 15287888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential induction and spread of tau pathology in young PS19 tau transgenic mice following intracerebral injections of pathological tau from Alzheimer's disease or corticobasal degeneration brains.
    Boluda S; Iba M; Zhang B; Raible KM; Lee VM; Trojanowski JQ
    Acta Neuropathol; 2015 Feb; 129(2):221-37. PubMed ID: 25534024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methods for Biochemical Isolation of Insoluble Tau in Rodent Models of Tauopathies.
    Canet G; Rocaboy E; Diego-Diàz S; Whittington RA; Julien C; Planel E
    Methods Mol Biol; 2024; 2754():323-341. PubMed ID: 38512674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tau pathology is present in vivo and develops in vitro in sensory neurons from human P301S tau transgenic mice: a system for screening drugs against tauopathies.
    Mellone M; Kestoras D; Andrews MR; Dassie E; Crowther RA; Stokin GB; Tinsley J; Horne G; Goedert M; Tolkovsky AM; Spillantini MG
    J Neurosci; 2013 Nov; 33(46):18175-89. PubMed ID: 24227726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early-onset cognitive deficits and axonal transport dysfunction in P301S mutant tau transgenic mice.
    Onishi T; Matsumoto Y; Hattori M; Obayashi Y; Nakamura K; Yano T; Horiguchi T; Iwashita H
    Neurosci Res; 2014 Mar; 80():76-85. PubMed ID: 24406748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metformin promotes tau aggregation and exacerbates abnormal behavior in a mouse model of tauopathy.
    Barini E; Antico O; Zhao Y; Asta F; Tucci V; Catelani T; Marotta R; Xu H; Gasparini L
    Mol Neurodegener; 2016 Feb; 11():16. PubMed ID: 26858121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Organotypic brain slice cultures of adult transgenic P301S mice--a model for tauopathy studies.
    Mewes A; Franke H; Singer D
    PLoS One; 2012; 7(9):e45017. PubMed ID: 22984603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repression of tau hyperphosphorylation by chronic endurance exercise in aged transgenic mouse model of tauopathies.
    Leem YH; Lim HJ; Shim SB; Cho JY; Kim BS; Han PL
    J Neurosci Res; 2009 Aug; 87(11):2561-70. PubMed ID: 19360903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beneficial effects of exercise in a transgenic mouse model of Alzheimer's disease-like Tau pathology.
    Belarbi K; Burnouf S; Fernandez-Gomez FJ; Laurent C; Lestavel S; Figeac M; Sultan A; Troquier L; Leboucher A; Caillierez R; Grosjean ME; Demeyer D; Obriot H; Brion I; Barbot B; Galas MC; Staels B; Humez S; Sergeant N; Schraen-Maschke S; Muhr-Tailleux A; Hamdane M; Buée L; Blum D
    Neurobiol Dis; 2011 Aug; 43(2):486-94. PubMed ID: 21569847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model.
    Yoshiyama Y; Higuchi M; Zhang B; Huang SM; Iwata N; Saido TC; Maeda J; Suhara T; Trojanowski JQ; Lee VM
    Neuron; 2007 Feb; 53(3):337-51. PubMed ID: 17270732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alzheimer's disease-like tau neuropathology leads to memory deficits and loss of functional synapses in a novel mutated tau transgenic mouse without any motor deficits.
    Schindowski K; Bretteville A; Leroy K; Bégard S; Brion JP; Hamdane M; Buée L
    Am J Pathol; 2006 Aug; 169(2):599-616. PubMed ID: 16877359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.